Skip to content
10-Q

Quarterly Report

RA PHARMACEUTICALS, INC.

0001104659-19-027979

← back to feed
Filed
May 9, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · May 2, 2019 42.3M sh
Capex Q1 2019 · Mar 31, 2019 $195K
Capex Q1 2019 · Mar 31, 2018 $29K
Operating Cash Flow Q1 2019 · Mar 31, 2019 −$18.02M
Operating Cash Flow Q1 2019 · Mar 31, 2018 −$15.52M
Cash And Equivalents Q1 2019 · Mar 31, 2019 $191.65M
Cash And Equivalents Q1 2019 · Dec 31, 2018 $209.82M
Cash And Equivalents Q1 2019 · Mar 31, 2018 $109.12M
Stockholders Equity Q1 2019 · Mar 31, 2019 $191.25M
Stockholders Equity Q1 2019 · Dec 31, 2018 $207.12M
Stockholders Equity Q1 2019 · Mar 31, 2018 $108.68M
Stockholders Equity Q1 2019 · Dec 31, 2017 $69.18M
Current Liabilities Q1 2019 · Mar 31, 2019 $9.73M
Current Liabilities Q1 2019 · Dec 31, 2018 $10.2M
Total Liabilities Q1 2019 · Mar 31, 2019 $13.82M
Total Liabilities Q1 2019 · Dec 31, 2018 $12.1M
Current Assets Q1 2019 · Mar 31, 2019 $195.56M
Current Assets Q1 2019 · Dec 31, 2018 $212.41M
Total Assets Q1 2019 · Mar 31, 2019 $205.07M
Total Assets Q1 2019 · Dec 31, 2018 $219.22M
Sga Expense Q1 2019 · Mar 31, 2019 $4.81M
Sga Expense Q1 2019 · Mar 31, 2018 $3.31M
Rd Expense Q1 2019 · Mar 31, 2019 $15.28M
Rd Expense Q1 2019 · Mar 31, 2018 $13.41M
Net Income Q1 2019 · Mar 31, 2019 −$19.04M
Net Income Q1 2019 · Mar 31, 2018 −$16.5M
Operating Income Q1 2019 · Mar 31, 2019 −$20.09M
Operating Income Q1 2019 · Mar 31, 2018 −$16.72M